NCT03823768 - Envarsus Neurotoxicity Burden in Liver Transplant Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

April 30, 2023

Study Completion Date

January 30, 2024

Conditions

NeurotoxicityLiver Transplant; Complications

Interventions

DRUG

Envarsus

Subjects in this group will take Envarsus daily for 6 months of treatment (goal 24 hour trough: 3-10 ng/mL) +/- adjunctive agent and prednisone.

DRUG

Tacrolimus Immediate release

Subjects in this group will take Tacrolimus immediate release for 6 months of treatment (goal 12 hour trough: 3-10 ng/mL) +/- adjunctive agent and prednisone.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston